<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-vaccines-08-00328">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>E.J.</given-names>
   </name>
   <name>
    <surname>Cha</surname>
    <given-names>G.W.</given-names>
   </name>
   <name>
    <surname>Ju</surname>
    <given-names>Y.R.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>W.J.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>Y.E.</given-names>
   </name>
  </person-group>
  <article-title>Prevalence of neutralizing antibodies to Japanese encephalitis virus among high-risk age groups in South Korea, 2010</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <elocation-id>e0147841</elocation-id>
  <pub-id pub-id-type="pmid">26807709</pub-id>
 </element-citation>
</ref>
